Kansas City, MO, United States of America

Jon Davis

This inventor holds 1 USPTO granted patent. Top assignee: Trinity Biotech, Primus Corporation. Active years: 2015.


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jon Davis - Innovator in Automated Chromatographic Analysis

Introduction

Jon Davis is a notable inventor based in Kansas City, MO (US). He has made significant contributions to the field of automated analysis, particularly in the medical diagnostics sector. His innovative work focuses on improving the efficiency and accuracy of blood sample analysis.

Latest Patents

Jon Davis holds a patent for a high-speed, automated chromatographic analyzer designed for the determination of nonglycated and glycated proteinaceous species in blood samples. This advanced analyzer features specialized sample transfer capabilities that allow for injection-to-injection analysis times of approximately one minute. The technology is particularly tailored for high-performance liquid chromatography (HPLC) analysis, enhancing the speed and reliability of testing for glycated and nonglycated proteins in biological fluids.

Career Highlights

Davis is currently associated with Trinity Biotech and Primus Corporation, where he applies his expertise in developing cutting-edge diagnostic tools. His work has been instrumental in advancing the capabilities of automated analyzers, making significant strides in the efficiency of blood analysis.

Collaborations

Throughout his career, Jon has collaborated with talented professionals, including Michael Farnet and Seth Powers. These partnerships have fostered innovation and contributed to the successful development of his patented technologies.

Conclusion

Jon Davis exemplifies the spirit of innovation in the field of automated analysis, with his patented technology paving the way for faster and more accurate blood testing. His contributions continue to impact the medical diagnostics industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…